Clinical Trials Sponsored by Instituto de Investigación en Oncología Radioterápica FEOR (IRAD-FEOR)
Total 11 results
-
Instituto de Investigación en Oncología Radioterápica...Instituto de Investigación en Oncología Radioterápica FEOR (IRAD-FEOR)RecruitingProstate Cancer | Stereotactic Body Radiation TherapySpain
-
Instituto de Investigación en Oncología Radioterápica...RecruitingProstate Cancer | Biochemical Recurrence | Androgen Deprivation Therapy | Salvage Radiotherapy | Metastases-free SurvivalSpain
-
Bernardino Clavo, MD, PhDInstituto de Salud Carlos III; Instituto Tecnologico Servicios Sanitarios,... and other collaboratorsTerminated
-
Instituto Aragones de Ciencias de la SaludAndaluz Health Service; Instituto de Salud Carlos III; Red de Investigación en... and other collaboratorsCompletedMultimorbidity | Polypharmacy | Other Diagnoses, Comorbidities, and ComplicationsSpain
-
Instituto Aragones de Ciencias de la SaludAndaluz Health Service; Instituto de Salud Carlos III; Red de Investigación en... and other collaboratorsCompletedMultimorbidity | Polypharmacy | Comorbidities and Coexisting Conditions | Clinical Decision-Support SystemsSpain
-
Universidad de GranadaUniversity of Otago; University of Jaén; Ministerio de Economía y Competitividad... and other collaboratorsRecruitingPhysical Activity | Body Composition | Behavior | Energy ExpenditureSpain
-
Hanoi University of Public HealthKarolinska Institutet; University of Copenhagen; National Children's Hospital... and other collaboratorsRecruitingAntibiotic Resistant Infection | Carbapenem-Resistant Enterobacteriaceae InfectionVietnam
-
Pontificia Universidad Catolica de ChileCenter of Excellence of Precision Medicine (CEMP); Advanced Center for Chronic... and other collaboratorsCompleted
-
The Netherlands Cancer InstituteEli Lilly and Company; Universitaire Ziekenhuizen KU Leuven; European Organisation... and other collaboratorsUnknown
-
The Netherlands Cancer InstituteEli Lilly and Company; Universitaire Ziekenhuizen KU Leuven; European Organisation... and other collaboratorsWithdrawnGalunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615)Colorectal Cancer MetastaticNetherlands
-
The Netherlands Cancer InstituteEli Lilly and Company; Universitaire Ziekenhuizen KU Leuven; European Organisation... and other collaboratorsUnknownColorectal Cancer Metastatic